| República da Coreia | Turki | Austria | |
| Terapi sel punca untuk PPOK | - | dari $12,000 | dari $32,000 |
| Terapi Dilatasi Balon Bronkoskopik untuk PPOK (Penyakit Paru Obstruktif Kronik) | - | dari $3,500 | dari $4,500 |
Bookimed tidak menambah biaya tambahan dalam harga perawatan Penyakit Paru Obstruktif Kronis. Tarif berasal dari daftar harga resmi klinik. Anda membayar langsung di klinik saat tiba di negara tujuan untuk perawatan Anda.
Bookimed berkomitmen pada keselamatan Anda. Kami hanya bekerja dengan institusi medis yang menjaga standar internasional tinggi dalam perawatan Penyakit Paru Obstruktif Kronis dan memiliki izin yang dibutuhkan untuk melayani pasien internasional di seluruh dunia.
Bookimed menawarkan bantuan ahli gratis. Koordinator medis pribadi mendukung Anda sebelum, selama, dan setelah perawatan, menyelesaikan semua masalah Anda. Anda tidak pernah sendirian dalam perjalanan perawatan Penyakit Paru Obstruktif Kronis Anda.
Dr. Hwang Dongin adalah ahli paru yang berfokus pada pengobatan paru dan perawatan kritis. Beliau memiliki spesialisasi dalam pneumonia, tuberkulosis paru, batuk kronis, penyakit paru kronis, rinitis alergi, asma, dan perawatan intensif paru.
Di Daelim Saint Mary's Hospital, beliau menjabat sebagai Kepala/Kepala Senior Pulmonologi dan sebagai Dokter Penanggung Jawab yang ditunjuk. Beliau juga merupakan Direktur Pelatihan Medis dan Pusat Kerja Sama Medis, serta menjabat sebagai CMO. Beliau adalah Profesor Klinis di St. Mary's Hospital, Universitas Katolik Korea. Beliau adalah dokter afiliasi dengan rumah sakit Samsung, Asan, Severance, dan Universitas Chung-Ang. Beliau bertugas di Komite Penasihat KMA. Beliau adalah anggota seumur hidup Akademi Tuberkulosis dan Penyakit Pernapasan Korea. Beliau adalah anggota penuh KASLC dan KAAACI. Beliau ditunjuk sebagai Peninjau Naskah Khusus untuk Masyarakat Kardiologi Korea. Beliau adalah anggota kelompok penelitian asma dan PPOK.
Dr. Lee Nagwon adalah ahli paru dan spesialis perawatan kritis. Beliau adalah Kepala Petugas Medis Pulmonologi di Rumah Sakit Naeun. Keahliannya meliputi pneumonia, tuberkulosis paru, batuk kronis, penyakit paru kronis, rinitis alergi, asma, dan perawatan intensif paru.
Beliau meraih gelar MD dan MS dalam Kedokteran dari Universitas Yonsei. Beliau menyelesaikan magang, residensi penyakit dalam, dan fellowship pulmonologi di Rumah Sakit Kristen Yonsei University Wonju Severance. Beliau pernah menjabat sebagai profesor tambahan di Yonsei University Wonju College of Medicine. Beliau juga pernah menjabat sebagai profesor klinis di Gachon University College of Medicine dan Inha University College of Medicine. Beliau adalah anggota penuh Asosiasi Penyakit Dalam Korea dan Akademi Tuberkulosis dan Penyakit Pernapasan Korea. Beliau menulis "Efek Diameter Bronkoskop pada Hasil Diagnostik Biopsi Paru Transbronkial pada Nodul Paru".
South Korean clinics prioritise inhaled bronchodilators such as LABA and LAMA as the primary treatment for COPD. Specialists commonly use a stepwise approach to manage symptoms and prevent flare-ups. Modern techniques are available at KOIHA-accredited institutions like Naeun Hospital. These include stem cell therapy and biological immunotherapy.
Bookimed Expert Insight: South Korea blends traditional internal medicine with regenerative research. Local clinics handle routine inhaler prescriptions. Meanwhile, institutions like Naeun Hospital are government-designated for regenerative medicine. This gives patients access to stem cell treatments alongside standard bronchodilators. It is a rare combination in most respiratory departments.
Patient Consensus: Patients find COPD care in South Korea highly efficient. They note that local internal medicine clinics provide quick assessments and affordable inhalers. For complex cases, moving to major hospitals is common. However, exercise and smoking cessation remain central to daily management.
COPD diagnosis in Korea requires a pulmonary function test at a specialist respiratory clinic. Specialist pulmonologists use spirometry to measure airflow after a bronchodilator. Diagnosis follows GOLD criteria. A ratio under 0.7 confirms airflow limitation. Testing is most frequent for adults over 40.
Bookimed Expert Insight: Korean respiratory care is highly centralised. Leading doctors like Dr Sang Heon Cho and Dr Lee Nagwon operate within major university-affiliated networks. Seeking treatment at accredited centres like NAEUN Hospital gives access to regenerative medicine and clinical research protocols not available in smaller primary clinics.
Patient Consensus: Patients emphasise that spirometry results are more definitive than X-rays. They advise waiting six weeks after a respiratory infection to ensure test accuracy. Bringing previous inhaler records and imaging results to original appointments in Korea helps doctors compare lung function trends immediately.
Specialists in South Korea commonly prescribe inhaled LABA–LAMA combinations as the first-choice treatment. These long-acting bronchodilators account for over 30% of local prescriptions. Hospitals also use triple therapies like Breztri Aerosphere for moderate-to-severe cases. Korean guidelines now focus on increasing inhaler use.
Bookimed Expert Insight: Patients in Seoul benefit from rapid access to newly launched triple therapies. Major clinics like Asan Medical Center often participate in global respiratory trials. Large university hospitals serve over 100,000 patients annually. This volume ensures specialists are highly experienced with complex pharmaceutical adjustments.
Patient Consensus: Travellers find Korean specialists very thorough during initial lung function tests. Patients in South Korea appreciate the detailed inhaler training clinics provide. They are taught how to use new devices correctly.
Specialised pulmonary rehabilitation (PR) programs in Korea operate primarily within major university hospitals. These structured programs include breathing retraining, inspiratory muscle exercises, and aerobic training. Facilities like Gangnam Severance Hospital offer pioneering centres. Leading pulmonologists such as Dr Sang Heon Cho provide specialist care for chronic obstructive pulmonary disease (COPD).
Bookimed Expert Insight: University hospitals in Seoul, like Yonsei Severance, are pioneers. NAEUN Hospital in Incheon, however, offers a high-capacity alternative. It serves 500,000 patients annually and holds specific government designations for regenerative medicine. This suggests patients can find research-backed care outside the capital. They do not sacrifice quality-certified safety standards.
Patient Consensus: Patients with chronic lung conditions find structured hospital-based programs transformative for daily function. They suggest looking at large tertiary hospitals. That is because smaller clinics rarely offer the necessary specialised respiratory equipment.
South Korea National Health Insurance Service (NHIS) covers essential COPD treatment. Coverage includes outpatient visits, hospitalisations, pulmonary function tests, and rehabilitation. Specialists at centres like NAEUN Hospital provide these services. Patients typically pay co-payments ranging from 30% to 60% of total costs.
Bookimed Expert Insight: While NHIS covers standard care, patients often choose private clinics for specialised pulmonary intensive care. Senior pulmonologists like Dr Lee Nagwon and Dr Hwang Dongin at NAEUN Hospital lead these departments. This hospital also holds a government designation for advanced regenerative therapies. This allows them to offer treatments beyond standard protocols. However, these may fall outside basic NHIS coverage.
Patient Consensus: Patients find standard COPD care costs manageable under the co-pay system in South Korea. They note that costs vary between small clinics and large hospitals. They recommend the NHIS English centre to confirm coverage for specific inhalers or imaging tests.
South Korean pulmonology specialists are found at major university hospitals in Seoul and Incheon. Leading experts include Dr Sang Heon Cho and Dr Lee Nagwon. These specialists hold international certifications. They effectively manage chronic lung conditions with diagnostics like low-dose chest CT and bronchial endoscopy.
Bookimed Expert Insight: While top-tier university hospitals provide high-level care, NAEUN HOSPITAL in Incheon serves 500,000 patients annually. It holds government designation for regenerative medicine. This suggests that patients can access sophisticated gene and stem cell therapies for COPD outside the busiest Seoul centres. They often experience shorter wait times for diagnostic testing.
Patient Consensus: Patients recommend visiting a major hospital for serious respiratory issues rather than local clinics. They suggest requesting both pulmonary function tests and CT scans to confirm diagnoses. They also recommend using international clinics for English-speaking support.